Journals
Publish with us
Publishing partnerships
About us
Blog
BioMed Research International
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
BioMed Research International
/
2022
/
Article
/
Tab 3
/
Review Article
Efficacy and Safety of Roxadustat in Patients with Chronic Kidney Disease: An Updated Meta-Analysis of Randomized Controlled Trials including 6,518 Patients
Table 3
Mean change from baseline in iron parameter and lipid levels in NDD study.
Parameter
value for heterogeneity (
,
)
SMD/WMD (95% CI)
value
Hepcidin
-1.56 (-2.63, -0.50)
Iron
-0.06 (-0.29, 0.18)
Transferrin
1.80 (1.53, 2.06)
Total iron-binding capacity
1.62 (1.39, 1.86)
Total cholesterol
-0.88 (-1.68, -0.09)
Ferritin
-52.68 (-62.68, -42.67)
Transferrin saturation
-5.57 (-7.47, -3.68)
LDL-cholesterol
-0.85 (-1.37, -0.34)
LDL-cholesterol: low-density lipoprotein cholesterol.